AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RAFLA, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by RAFLA, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

TUMORS OF THE UPPER UROTHELIUM

SAMEER RAFLA M.D., PH.D.

Forty-two cases of malignant tumors of renal pelvis were reviewed: 28 were transitional cell carcinomas; and 14 were squamous cell carcinomas.

The natural history and spread of the disease is discussed in detail. Transitional cell carcinomas spread primarily to the ureter (40 per cent), followed closely by the renal bed (33 per cent) and bladder (30 per cent). Squamous cell carcinomas spread primarily through the renal bed (60 per cent), followed by the draining lymph nodes (28 per cent). The spread to other regions (bones, splanchnic organs, chest ... etc.), occurred with relatively less frequency, but more in squamous than transitional cell carcinomas. Transitional cell carcinomas seem to have a longer natural history than squamous cell carcinomas. Recurrences in bladder and the remainder of the urothelium seem to be controlled for relatively long periods of time, while those in lymph nodes and renal bed seem to be rapidly fatal.

The results of treatment and factors influencing them are discussed. Patients suffering from transitional cell carcinomas faired better than those with squamous cell carcinomas at the 5 year mark (25 and 15 per cent, respectively), but the 10 year results are poor in both.

The role of radiotherapy in the treatment of these tumors and the influencing factors are also discussed in detail. The response of these tumors to radiotherapy seems to be akin to that of the lower urothelium (bladder), provided adequate dosage is delivered to the relevant volume at the proper moment in time.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the American Roentgen Ray Society.